Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Research Report
Nonsteroidal Anti-inflammatory Drugs: A Comprehensive Clinical and Pharmacological Review
Section 1: Introduction to NSAIDs: A Cornerstone of Modern Pharmacotherapy
1.1. Defining the Drug Class and Its Historical Context
Nonsteroidal anti-inflammatory drugs (NSAIDs) represent a class of medications renowned for their analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) properties.[1] They are among the most widely prescribed and utilized therapeutic agents worldwide, forming the foundation of treatment for a vast array of acute and chronic conditions. The term "non-steroidal" itself provides a crucial historical insight into their development. Coined around 1960, it was specifically chosen to differentiate this emerging class of drugs from corticosteroids, which, despite their potent anti-inflammatory effects, had gained a negative reputation in the 1950s due to significant and often severe side effects associated with their overuse.[3] This distinction positioned NSAIDs as a new, seemingly safer alternative for managing inflammation and pain. This historical search for a therapeutic agent that could separate efficacy from toxicity is a recurring theme that has defined the evolution of NSAIDs, foreshadowing later developments such as the creation of COX-2 selective inhibitors, which were themselves an attempt to solve the toxicity problems of their predecessors.
1.2. Overview of Core Therapeutic Properties
The clinical utility of NSAIDs stems from their three primary pharmacological actions:
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/03/25 | Phase 4 | Completed | |||
2025/01/29 | Phase 4 | Recruiting | Tomsk Cardiology Research Institute | ||
2024/11/04 | Phase 4 | Recruiting | |||
2024/01/31 | Not Applicable | Completed | Kayseri City Hospital | ||
2024/01/19 | Early Phase 1 | Not yet recruiting | |||
2023/02/10 | Phase 4 | Recruiting | |||
2022/09/02 | Phase 4 | Active, not recruiting | |||
2022/03/02 | Early Phase 1 | Withdrawn | |||
2022/02/15 | Phase 4 | Completed | |||
2022/01/12 | Not Applicable | Recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
No Health Canada approvals found for this drug. |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.